Padmanabh P. Bhatt - 04 May 2023 Form 4 Insider Report for SUPERNUS PHARMACEUTICALS, INC. (SUPN)

Role
Sr. VP of IP, CSO
Signature
/s/ Timothy C. Dec, as attorney-in-fact
Issuer symbol
SUPN
Transactions as of
04 May 2023
Net transactions value
$0
Form type
4
Filing time
08 May 2023, 17:00:09 UTC
Previous filing
12 Apr 2023
Next filing
12 May 2023
SEC
View on sec.gov

Sponsored

Quoteable Key Fact

"Padmanabh P. Bhatt filed Form 4 for SUPERNUS PHARMACEUTICALS, INC. (SUPN) on 08 May 2023."

Quick Takeaways

  • This page summarizes Padmanabh P. Bhatt's Form 4 filing for SUPERNUS PHARMACEUTICALS, INC. (SUPN).
  • 1 reported transaction and 1 derivative row are listed below.
  • Filing timestamp: 08 May 2023, 17:00.

What Changed

  • Previous filing in this sequence was filed on 12 Apr 2023.
  • Current net transaction value: $0.

Why This Matters

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Official SEC Source

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

See Original Filing

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding SUPN Common Stock 4,747 04 May 2023 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SUPN Performance Share Unit Award $0 +750 $0.000000 750 04 May 2023 Common Stock 750 $0.000000 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On April 30, 2021, the Reporting Person was awarded Performance Share Units a portion of which vested upon the achievement of individual performance objectives within a defined performance period.

Sponsored